Skip to main content

Fight against pandemics

Women and children’s health

Funding and quality of aid

Research and Development

Opinions

TB R&D
Tuberculosis
Blog series

If we have strong political will at the upcoming UNHLM on TB in September 2023, I genuinely believe we will be closer to our goal of ending TB by 2030.

By Rhea Lobo, an international award-winning filmmaker with a background in health journalism, a Tuberculosis (TB) survivor and a Board Member of the Stop TB Partnership.
TB R&D
Tuberculosis
Blog series

It’s a crucial moment for us in TB. We have so many opportunities in terms of R&D that shouldn’t be wasted.

By Dr. Lucica Ditiu, a Romanian physician and Executive Director of the Stop TB Partnership.
TB R&D
Tuberculosis
Blog series

There really are grounds for optimism, but investment is still too low.

By Olivier Neyrolles, a researcher at CNRS and the director of IPBS-Toulouse.

Social network

To stay in touch with Global Health Advocates,
follow us on Twitter

#UNGA2023 #2023UNHLM | Lors d'un side-event dédié aux systèmes de santé inclusifs, @AmprouAnne rappelle que « le multilatéralisme, y compris en matière de 💰, doit être le moteur de la nouvelle architecture en #santémondiale » & la solidarité un principe fondamental.

🗣️Le @GlobalFund a publié son rapport de résultats sur l’année 2022. Découvrez-le👇
🥳Depuis sa création, l'organisation a sauvé 59 millions de vies dans le 🌍, contribuant activement à la réalisation de l'#ODD3.
💪Continuons la lutte contre le #sida, la #TB et le #paludisme !